SUBSCRIBE
SUBSCRIBE
News   FDA

Warner Chilcott Gets FDA OK for 150 mg Acne Drug

June 23, 2008 | 
1 min read
Warner Chilcott Ltd. said Monday the Food and Drug Administration approved a 150 mg strength of Doryx delayed-release tablets as a treatment for severe acne.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
New York City, NY, USA - August 22, 2022: Pfizer world headquarters in New York City, USA. Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation.
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
The COVID-19 vaccine in glass bottles for prevention, immunization, and treatment of coronavirus infection on a green background. Space for text. Concept of medical and vaccine.
Vaccines
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines
May 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
May 21, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
A person and a group of people are separated by a yellow line. Establishing contact. Distrust. Quarantine. Distance with strangers. Barrier to understanding, difficult integration. Rejection, refusal.
Lymphoma
Roche’s Genentech Fails to Win Adcomm Backing for Columvi Expansion
May 21, 2025
 · 
2 min read
 · 
Tristan Manalac